RHP slips behind peers as JP Morgan lifts target and Q3 results loom

Ryman Hospitality Properties gained 4.4% over the past week to close at $129.98, a decent move in absolute terms but trailing the median of its closest lodging REIT peers. XHR rose 5.9%, HST added 6.8%, and APLE gained 7.7% over the same period. The underperformance is modest, but it comes with Q3 results due on November 2, and the Street just nudged its target higher.

JP Morgan's Daniel Politzer raised his price target on RHP to $138 from $129 this morning, maintaining his Overweight rating. The timing matters: the stock is now trading at $129.98, just inside that old target, so the revision restores meaningful upside on paper. The broader analyst picture is constructive. Barclays trimmed its target to $143 from $147 last week but held its Overweight rating. Raymond James, Truist and Citigroup all raised targets through September. The consensus mean sits at $140.14, roughly 8% above the current price, with no recent downgrades in the log. One structural caveat: the prior quarter's earnings history shows four consecutive negative day-one reactions, ranging from 3.4% to 5.3% lower. The Street may be buyers ahead of the print, but the stock has consistently faded on the day results arrive.

Short interest is a secondary story here, not the primary one. At 4.5% of the free float, the short position has shrunk about 6% over the past week as the stock climbed, coming down from a local peak near 3.7 million shares in late September to roughly 2.8 million today. Borrowing conditions give no signal of stress: the cost to borrow is just 0.41%, down 5% on the week and 12% over the past month. Availability is 1,363%, meaning there are more than thirteen shares available to borrow for every one already shorted. That is a large and comfortable pool, and it has been expanding as short interest retreats, a clear contrast to a stock under active short pressure.

Factor positioning adds some texture. The forward earnings revision score ranks in the 93rd percentile, a standout number that reflects how consistently analysts have been lifting their estimates. The dividend score ranks in the 86th percentile, though the dividend history data in the system is stale and predates the pandemic suspension. The short score has drifted lower this week to 40.3, down from 43.8 a week ago, consistent with shorts covering and the borrow market loosening. The ORTEX short score at 40 is below the midpoint, placing RHP in the less-shorted half of the universe for its sector. EV/EBITDA runs at 11.85x, up slightly over the week but broadly stable over thirty days.

On the institutional side, BlackRock has been building its position. It last reported 11.2 million shares, or roughly 16.4% of the company, and added 390,587 shares in the quarter to September 30. T. Rowe Price added 644,229 shares in the same period, taking its stake to 2.3% of shares. The 13D/G register carries no activist filings. State Street and Vanguard entities are on the 13G register as passive holders, and all filings are Schedule 13G rather than 13D, so there is no activist on the register to note. Stakes are as last disclosed around the 5% threshold, and a holder dropping below that level may not file again.

The date to track is November 2, when RHP reports Q3 results. The prior four prints each produced a negative first-day reaction, so the gap between the analyst consensus target and where the stock currently trades will be tested against whatever the company reports on group bookings, hotel revenue per available room, and management's commentary on corporate event demand heading into 2026.